iCarbonX
2 known investors
Find your way into iCarbonX
Sign up to see every warm intro you have to iCarbonX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the iCarbonX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iCarbonX (碳云智能) develops multi-omics testing and AI-based technologies — including ctDNA detection, silicon-based biochips, TCR peptide chips, and AI drug design — to support cancer neoantigen research, clinical diagnostics, new drug development, and health management. The company applies these platforms across precision testing, personalized therapy design, and biological-age/anti-aging health assessment.
Investors · 2
Founder mafia
4 people who came through iCarbonX went on to found or lead other companies.
Frequently asked questions
- What does iCarbonX do?
- iCarbonX (碳云智能) develops multi-omics testing and AI-based technologies — including ctDNA detection, silicon-based biochips, TCR peptide chips, and AI drug design — to support cancer neoantigen research, clinical diagnostics, new drug development, and health management. The company applies these platforms across precision testing, personalized therapy design, and biological-age/anti-aging health assessment.
- Who are iCarbonX's investors?
- iCarbonX's investors include Quan Capital, Third Point Ventures.


